NCT05174884View on ClinicalTrials.gov

Casea S Contraceptive Implants (Casea S) Trial

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 13, 2023

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions
Contraception
Interventions
DRUG

22.2 mg Etonogestrel (ENG)

Subdermal insertion of a single Casea S pellet (22.2 mg ENG) in healthy female participants

DRUG

44.4 mg Etonogestrel (ENG)

Subdermal insertion of a two Casea S pellet (44.4 mg ENG) in healthy female participants

Trial Locations (1)

10401

Clinica Profamilia, Santo Domingo

All Listed Sponsors
collaborator

Bill and Melinda Gates Foundation

OTHER

lead

FHI 360

OTHER

NCT05174884 - Casea S Contraceptive Implants (Casea S) Trial | Biotech Hunter | Biotech Hunter